Registro:

Referencias:

• Redman, C.W., Sargent, I.L., Latest advances in understanding preeclampsia (2005) Science, 308 (5728), pp. 1592-1594. , DOI 10.1126/science.1111726
• Roberts, J.M., Lain, K.Y., Recent insights into the pathogenesis of pre-eclampsia (2002) Placenta, 23 (5), pp. 359-372. , DOI 10.1053/plac.2002.0819
• Maynard, S.E., Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia (2003) J Clin Invest, 111 (5), pp. 649-658
• Venkatesha, S., Toporsian, M., Lam, C., Hanai, J.-I., Mammoto, T., Kim, Y.M., Bdolah, Y., Karumanchi, S.A., Soluble endoglin contributes to the pathogenesis of preeclampsia (2006) Nature Medicine, 12 (6), pp. 642-649. , DOI 10.1038/nm1429, PII N1429
• Naicher, T., Khedun, S.M., Moodley, J., Pijnenborg, R., Quantitative analysis of trophoblast invasion in preeclampsia (2003) Acta Obstetricia et Gynecologica Scandinavica, 82 (8), pp. 722-729. , DOI 10.1034/j.1600-0412.2003.00220.x
• Herse, F., Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia (2007) Hypertension, 49 (3), pp. 604-611
• Zhou, C.C., Angiotensin receptor agonistic autoantibodies induce preeclampsia in pregnant mice (2008) Nat Med, 14 (8), pp. 855-862
• Phillips, B., Knisley, K., Weitlauf, K.D., Dorsett, J., Lee, V., Weitlauf, H., Differential expression of two beta-galactoside-binding lectins in the reproductive tracts of pregnant mice (1996) Biology of Reproduction, 55 (3), pp. 548-558
• Von, W.M., Wang, X., Gabius, H.-J., Strowitzki, T., Galectin fingerprinting in human endometrium and decidua during the menstrual cycle and in early gestation (2005) Molecular Human Reproduction, 11 (3), pp. 189-194. , DOI 10.1093/molehr/gah144
• Tirado-González, I., Galectin-1 influences trophoblast immune evasion and emerges as a predictive factor for the outcome of pregnancy (2013) Mol Hum Reprod, 19 (1), pp. 43-53
• Blois, S.M., Ilarregui, J.M., Tometten, M., Garcia, M., Orsal, A.S., Cordo-Russo, R., Toscano, M.A., Arck, P.C., A pivotal role for galectin-1 in fetomaternal tolerance (2007) Nature Medicine, 13 (12), pp. 1450-1457. , DOI 10.1038/nm1680, PII NM1680
• Kopcow, H.D., T cell apoptosis at the maternal-fetal interface in early human pregnancy, involvement of galectin-1 (2008) Proc Natl Acad Sci USA, 105 (47), pp. 18472-18477
• Fischer, I., Stimulation of syncytium formation in vitro in human trophoblast cells by galectin-1 (2010) Placenta, 31 (9), pp. 825-832
• Kolundžić, N., Galectin-1 is part of human trophoblast invasion machinery - A functional study in vitro (2011) PLoS ONE, 6 (12), pp. e28514
• Hsieh, S.H., Ying, N.W., Wu, M.H., Chiang, W.F., Hsu, C.L., Wong, T.Y., Jin, Y.T., Chen, Y.L., Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells (2008) Oncogene, 27 (26), pp. 3746-3753. , DOI 10.1038/sj.onc.1211029, PII 1211029
• Griffioen, A.W., Van Der, S.D.W.J., Barendsz-Janson, A.F., Cox, A., Struijker, B.H.A.J., Hillen, H.F.P., Mayo, K.H., Anginex, a designed peptide that inhibits angiogenesis (2001) Biochemical Journal, 354 (2), pp. 233-242. , DOI 10.1042/0264-6021:3540233
• Thijssen, V.L.J.L., Postel, R., Brandwijk, R.J.M.G.E., Dings, R.P.M., Nesmelova, I., Satijn, S., Verhofstad, N., Griffioen, A.W., Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy (2006) Proceedings of the National Academy of Sciences of the United States of America, 103 (43), pp. 15975-15980. , DOI 10.1073/pnas.0603883103
• Plaks, V., Uterine DCs are crucial for decidua formation during embryo implantation in mice (2008) J Clin Invest, 118 (12), pp. 3954-3965
• Miller, D.W., Vosseler, S., Mirancea, N., Hicklin, D.J., Bohlen, P., Volcker, H.E., Holz, F.G., Fusenig, N.E., Rapid vessel regression, protease inhibition, and stromal normalization upon short-term vascular endothelial growth factor receptor 2 inhibition in skin carcinoma heterotransplants (2005) American Journal of Pathology, 167 (5), pp. 1389-1403
• Huppertz, B., Placental origins of preeclampsia: Challenging the current hypothesis (2008) Hypertension, 51 (4), pp. 970-975
• Thijssen, V.L., Tumor cells secrete galectin-1 to enhance endothelial cell activity (2010) Cancer Res, 70 (15), pp. 6216-6224
• Halder, J.B., Zhao, X., Soker, S., Paria, B.C., Klagsbrun, M., Das, S.K., Dey, S.K., Differential expression of VEGF isoforms and VEGF164-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF164 in vascular permeability and angiogenesis during implantation (2000) Genesis, 26 (3), pp. 213-224. , DOI 10.1002/(SICI)1526-968X(200003)26:3<213::AID-G
• Douglas, N.C., Vascular endothelial growth factor receptor 2 (VEGFR-2) functions to promote uterine decidual angiogenesis during early pregnancy in the mouse (2009) Endocrinology, 150 (8), pp. 3845-3854
• Ferrara, N., Davis-Smyth, T., The biology of vascular endothelial growth factor (1997) Endocrine Reviews, 18 (1), pp. 4-25. , DOI 10.1210/er.18.1.4
• Matsumoto, H., Cyclooxygenase-2 differentially directs uterine angiogenesis during implantation in mice (2002) J Biol Chem, 277 (32), pp. 29260-29267
• Torry, D.S., Leavenworth, J., Chang, M., Maheshwari, V., Groesch, K., Ball, E.R., Torry, R.J., Angiogenesis in implantation (2007) Journal of Assisted Reproduction and Genetics, 24 (7), pp. 303-315. , DOI 10.1007/s10815-007-9152-7, A Symposium on Human Implantation
• Cox, P., Marton, T., Pathological assessment of intrauterine growth restriction (2009) Best Pract Res Clin Obstet Gynaecol, 23 (6), pp. 751-764
• McMaster, M.T., Zhou, Y., Fisher, S.J., Abnormal placentation and the syndrome of preeclampsia (2004) Seminars in Nephrology, 24 (6 SPEC.ISS.), pp. 540-547. , DOI 10.1016/j.semnephrol.2004.07.002, PII S027092950400124X
• Baston-Buest, D.M., Expression of the vascular endothelial growth factor receptor neuropilin-1 at the human embryo-maternal interface (2011) Eur J Obstet Gynecol Reprod Biol, 154 (2), pp. 151-156
• Pan, Q., Chanthery, Y., Liang, W.-C., Stawicki, S., Mak, J., Rathore, N., Tong, R.K., Watts, R.J., Blocking Neuropilin-1 Function Has an Additive Effect with Anti-VEGF to Inhibit Tumor Growth (2007) Cancer Cell, 11 (1), pp. 53-67. , DOI 10.1016/j.ccr.2006.10.018, PII S1535610806003679
• Liu, A.X., Proteomic analysis on the alteration of protein expression in the placental villous tissue of early pregnancy loss (2006) Biol Reprod, 75 (3), pp. 414-420
• Molvarec, A., Peripheral blood galectin-1-expressing T and natural killer cells in normal pregnancy and preeclampsia (2011) Clin Immunol, 139 (1), pp. 48-56
• Redman, C.W.G., Sacks, G.P., Sargent, I.L., Preeclampsia: An excessive maternal inflammatory response to pregnancy (1999) American Journal of Obstetrics and Gynecology, 180 (2 I), pp. 499-506. , DOI 10.1016/S0002-9378(99)70239-5
• Munaut, C., Differential expression of Vegfr-2 and its soluble form in preeclampsia (2012) PLoS ONE, 7 (3), pp. e33475
• Redman, C.W., Sargent, I.L., Placental stress and pre-eclampsia: A revised view (2009) Placenta, 30 (SUPPL. A), pp. S38-S42
• Than, N.G., Erez, O., Wildman, D.E., Tarca, A.L., Edwin, S.S., Abbas, A., Hotra, J., Romero, R., Severe preeclampsia is characterized by increased placental expression of galectin-1 (2008) Journal of Maternal-Fetal and Neonatal Medicine, 21 (7), pp. 429-442. , DOI 10.1080/14767050802041961, PII 794216965
• Iwata, M., Matsuzaki, N., Shimizu, I., Mitsuda, N., Nakayama, M., Suehara, N., Prenatal detection of ischemic changes in the placenta of the growth-retarded fetus by Doppler flow velocimetry of the maternal uterine artery (1993) Obstetrics and Gynecology, 82 (4 I), pp. 494-499
• Dokras, A., Hoffmann, D.S., Eastvold, J.S., Kienzle, M.F., Gruman, L.M., Kirby, P.A., Weiss, R.M., Davisson, R.L., Severe feto-placental abnormalities precede the onset of hypertension and proteinuria in a mouse model of preeclampsia (2006) Biology of Reproduction, 75 (6), pp. 899-907. , DOI 10.1095/biolreprod.106.053603
• Barrientos, G., CXCR4(+) dendritic cells promote angiogenesis during embryo implantation in mice (2012) Angiogenesis, 16 (2), pp. 417-427
• Herse, F., Cytochrome P450 subfamily 2J polypeptide 2 expression and circulating epoxyeicosatrienoic metabolites in preeclampsia (2012) Circulation, 126 (25), pp. 2990-2999
• Ahmed, A., Singh, J., Khan, Y., Seshan, S.V., Girardi, G., A new mouse model to explore therapies for preeclampsia (2010) PLoS ONE, 5 (10), pp. e13663
• Wallukat, G., Homuth, V., Fischer, T., Lindschau, C., Horstkamp, B., Jupner, A., Baur, E., Luft, F.C., Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor (1999) Journal of Clinical Investigation, 103 (7), pp. 945-952

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------